alanine + arginine + aspartic acid + 17 other active ingredients: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
alanine + arginine + aspartic acid + 17 other active ingredients: clinical details
Prescribing considerations
- Individualise total nutritional, fluid and electrolyte provision; the fixed bag composition may not meet every requirement simultaneously.
- Correct severe fluid, electrolyte and metabolic disturbances before starting.
- Assess refeeding risk in severely malnourished patients and ensure appropriate vitamins, trace elements and electrolytes.
- Use only through central venous access because of high osmolarity.
- Confirm compatibility and emulsion stability before adding supplements or co-administering other infusions.
Contraindications and cautions
- Premature neonates, infants and children younger than 2 years
- Hypersensitivity to egg, soya, peanut, corn or corn products, or another ingredient
- Congenital amino-acid metabolism disorders
- Severe hyperlipidaemia or severe lipid-metabolism disorders with hypertriglyceridaemia
- Severe hyperglycaemia
Monitoring
- Fluid and electrolyte balance, serum osmolarity and acid–base status
- Blood glucose and triglycerides
- Liver and kidney function; consider ammonia when hepatic insufficiency is suspected
- Full blood count, platelets and coagulation
- Central-line site, catheter function and evidence of infection
- Signs of refeeding disturbance, extravasation, hypersensitivity and fat overload
Clinical pharmacology
The formulation combines glucose, 17 L-amino acids and an olive-oil-predominant lipid emulsion containing some soya-bean oil. These substrates are distributed, metabolised and eliminated as when administered separately, supporting energy and nitrogen balance.
Formulation and product differences
- The three-compartment emulsion does not contain a full electrolyte complement, allowing electrolytes to be tailored separately.
- It contains purified egg phospholipids and glucose derived from corn, relevant to allergy assessment.
- Vitamins and trace elements are not present in amounts sufficient to meet full requirements and generally require supplementation.
alanine + arginine + aspartic acid + 17 other active ingredients interactions
Formal interaction studies have not been performed. Important practical interactions concern infusion compatibility, lipid metabolism and laboratory testing.
Blood products
Do not administer through the same tubing because pseudoagglutination may occur.
Ampicillin or fosphenytoin
Do not mix with the emulsion or administer through the same infusion line because precipitation may occur.
Heparin
Can temporarily alter lipoprotein-lipase activity and triglyceride clearance.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.